Gabon, Douglas M.

HRN: 25-48-51  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/16/2025
04/22/2025
IV
500 Mg
Q8
Cholecystitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: